<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The expression of GOK, a gene recently identified at 11p15.5, was studied in <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo>, and <z:e sem="disease" ids="C0206743" disease_type="Neoplastic Process" abbrv="">rhabdoid tumor</z:e> cell lines </plain></SENT>
<SENT sid="1" pm="."><plain>In these <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, deletions at 11p15 and suppression of tumorigenicity induced by a <z:mpath ids='MPATH_458'>normal</z:mpath> human chromosome 11 were previously demonstrated </plain></SENT>
<SENT sid="2" pm="."><plain>Whereas <z:hpo ids='HP_0003002'>breast cancer</z:hpo> cell lines express readily detectable levels of GOK <z:chebi fb="2" ids="33699">mRNA</z:chebi>, expression is absent in <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo> and <z:e sem="disease" ids="C0206743" disease_type="Neoplastic Process" abbrv="">rhabdoid tumor</z:e> cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>This is in contrast with the high expression of GOK in skeletal muscle, the <z:mpath ids='MPATH_458'>normal</z:mpath> tissue of origin of <z:hpo ids='HP_0002859'>rhabdomyosarcomas</z:hpo>, suggesting that down-regulation of GOK expression could be involved in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development </plain></SENT>
<SENT sid="4" pm="."><plain>In agreement with this hypothesis, transfection of GOK cDNA into G401 derived from a <z:e sem="disease" ids="C0206743" disease_type="Neoplastic Process" abbrv="">rhabdoid tumor</z:e> and RD cells derived from a <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo> that do not express detectable levels of GOK <z:chebi fb="2" ids="33699">mRNA</z:chebi>, induced cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Because GOK expression is not compatible with growth of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, these results support the hypothesis that loss of GOK expression plays a role in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> establishment or progression and suggest that GOK may act as a recessive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene in <z:hpo ids='HP_0002859'>rhabdomyosarcomas</z:hpo> and <z:e sem="disease" ids="C0206743" disease_type="Neoplastic Process" abbrv="">rhabdoid tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>On the contrary, transfection of GOK cDNA into the <z:hpo ids='HP_0003002'>breast cancer</z:hpo> cell line HBL100 produced no detectable effects, indicating that the growth-suppressive effect of GOK in RD and G401 cells was specific </plain></SENT>
<SENT sid="7" pm="."><plain>Because <z:hpo ids='HP_0002859'>rhabdomyosarcomas</z:hpo> have been observed in cases of <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>, a <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorder</z:e> linked to 11p15, a role of GOK in this disease cannot be excluded </plain></SENT>
</text></document>